RND2
gene geneOn this page
Also known as Rho7RhoN
Summary
RND2 (Rho family GTPase 2, HGNC:18315) is a protein-coding gene on chromosome 17q21.31, encoding Rho-related GTP-binding protein RhoN (P52198). May be specifically involved in neuronal and hepatic functions.
This gene encodes a member of the Rho GTPase family, whose members play a key role in the regulation of actin cytoskeleton organization in response to extracellular growth factors. This particular family member has been implicated in the regulation of neuronal morphology and endosomal trafficking. The gene localizes to chromosome 17 and is the centromeric neighbor of the breast-ovarian cancer susceptibility gene BRCA1.
Source: NCBI Gene 8153 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 39 total
- MANE Select transcript:
NM_005440
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18315 |
| Approved symbol | RND2 |
| Name | Rho family GTPase 2 |
| Location | 17q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Rho7, RhoN |
| Ensembl gene | ENSG00000108830 |
| Ensembl biotype | protein_coding |
| OMIM | 601555 |
| Entrez | 8153 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 retained_intron, 2 protein_coding
ENST00000587117, ENST00000587250, ENST00000710494, ENST00000916371
RefSeq mRNA: 1 — MANE Select: NM_005440
NM_005440
CCDS: CCDS11452
Canonical transcript exons
ENST00000587250 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000727580 | 43025960 | 43026047 |
| ENSE00000727584 | 43027183 | 43027292 |
| ENSE00000727589 | 43028061 | 43028195 |
| ENSE00002893091 | 43028432 | 43032041 |
| ENSE00003663398 | 43025231 | 43025449 |
Expression profiles
Bgee: expression breadth ubiquitous, 213 present calls, max score 96.53.
FANTOM5 (CAGE): breadth broad, TPM avg 4.4679 / max 159.4089, expressed in 542 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 161050 | 3.9653 | 510 |
| 161052 | 0.3574 | 181 |
| 161051 | 0.1453 | 86 |
Top tissues by expression
289 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.53 | gold quality |
| medial globus pallidus | UBERON:0002477 | 96.40 | gold quality |
| spinal cord | UBERON:0002240 | 95.24 | gold quality |
| globus pallidus | UBERON:0001875 | 95.10 | gold quality |
| hypothalamus | UBERON:0001898 | 94.87 | gold quality |
| substantia nigra | UBERON:0002038 | 94.52 | gold quality |
| midbrain | UBERON:0001891 | 94.13 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 93.32 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.99 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 92.52 | gold quality |
| left testis | UBERON:0004533 | 91.03 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 90.73 | gold quality |
| right testis | UBERON:0004534 | 90.70 | gold quality |
| ventral tegmental area | UBERON:0002691 | 90.68 | gold quality |
| pons | UBERON:0000988 | 90.66 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 90.25 | gold quality |
| medulla oblongata | UBERON:0001896 | 89.85 | gold quality |
| putamen | UBERON:0001874 | 89.83 | gold quality |
| caudate nucleus | UBERON:0001873 | 89.53 | gold quality |
| amygdala | UBERON:0001876 | 88.85 | gold quality |
| testis | UBERON:0000473 | 88.69 | gold quality |
| sperm | CL:0000019 | 87.20 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 87.00 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 86.75 | gold quality |
| male germ cell | CL:0000015 | 86.01 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 85.83 | gold quality |
| right frontal lobe | UBERON:0002810 | 85.19 | gold quality |
| inferior olivary complex | UBERON:0002127 | 85.11 | gold quality |
| cingulate cortex | UBERON:0003027 | 84.82 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 84.59 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-70580 | no | 4.93 |
| E-ANND-3 | no | 3.53 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): NEUROG2
miRNA regulators (miRDB)
117 targeting RND2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-4671-3P | 99.88 | 72.46 | 1045 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-4271 | 99.88 | 68.32 | 2244 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
Literature-anchored findings (GeneRIF, showing 5)
- Socius is a novel Rnd GTPase-interacting protein involved in disassembly of actin stress fibers (PMID:11940653)
- The RND2 mRNA levels increased significantly after gestation in myometria. (PMID:16311049)
- Rnd2 regulates neurite outgrowth by functioning as the RhoA activator through Pragmin, in contrast to Rnd1 and Rnd3 inhibiting RhoA signaling (PMID:16481321)
- Rho7 expression was increased in the neurons of patients with IE compared with control samples, which indicated that Rho7 may be associated with the progression of IE or act as a potential target for IE treatment. (PMID:29039551)
- RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway. (PMID:32867814)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rnd2 | ENSDARG00000070735 |
| mus_musculus | Rnd2 | ENSMUSG00000001313 |
| rattus_norvegicus | Rnd2 | ENSRNOG00000020698 |
| rattus_norvegicus | ENSRNOG00000065380 |
Paralogs (22): RHOBTB2 (ENSG00000008853), RHOA (ENSG00000067560), CDC42 (ENSG00000070831), RHOBTB1 (ENSG00000072422), RHOV (ENSG00000104140), RND3 (ENSG00000115963), RHOU (ENSG00000116574), RHOQ (ENSG00000119729), RHOJ (ENSG00000126785), RHOT1 (ENSG00000126858), RAC2 (ENSG00000128340), RAC1 (ENSG00000136238), RHOF (ENSG00000139725), RHOT2 (ENSG00000140983), RHOB (ENSG00000143878), RHOC (ENSG00000155366), RHOBTB3 (ENSG00000164292), RHOH (ENSG00000168421), RAC3 (ENSG00000169750), RND1 (ENSG00000172602), RHOD (ENSG00000173156), RHOG (ENSG00000177105)
Protein
Protein identifiers
Rho-related GTP-binding protein RhoN — P52198 (reviewed: P52198)
Alternative names: Rho family GTPase 2, Rho-related GTP-binding protein Rho7, Rnd2
All UniProt accessions (1): P52198
UniProt curated annotations — full annotation on UniProt →
Function. May be specifically involved in neuronal and hepatic functions. Is a C3 toxin-insensitive member of the Rho subfamily.
Subunit / interactions. Interacts with the Rho-GAP domain of RACGAP1. Interacts with UBXD5. Interacts with PRAG1.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome membrane.
Tissue specificity. Highly expressed in testis.
Similarity. Belongs to the small GTPase superfamily. Rho family.
RefSeq proteins (1): NP_005431* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001806 | Small_GTPase | Family |
| IPR003578 | Small_GTPase_Rho | Family |
| IPR005225 | Small_GTP-bd | Domain |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR041842 | RhoN | Family |
Pfam: PF00071
UniProt features (10 total): binding site 3, chain 1, propeptide 1, region of interest 1, short sequence motif 1, compositionally biased region 1, modified residue 1, lipid moiety-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P52198-F1 | 83.40 | 0.74 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (3): 14–21; 61–65; 119–122
Post-translational modifications (2): 224, 224
Function
Pathways and Gene Ontology
Reactome pathways
5 pathways
| ID | Pathway |
|---|---|
| R-HSA-9696270 | RND2 GTPase cycle |
| R-HSA-162582 | Signal Transduction |
| R-HSA-194315 | Signaling by Rho GTPases |
| R-HSA-9012999 | RHO GTPase cycle |
| R-HSA-9716542 | Signaling by Rho GTPases, Miro GTPases and RHOBTB3 |
MSigDB gene sets: 169 (showing top):
GOBP_REGULATION_OF_COLLATERAL_SPROUTING, GOCC_SECRETORY_GRANULE, GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH, GOBP_GROWTH, GOBP_NEUROGENESIS, BROWNE_HCMV_INFECTION_16HR_UP, GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN, GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS, MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP, GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH
GO Biological Process (6): actin filament organization (GO:0007015), signal transduction (GO:0007165), small GTPase-mediated signal transduction (GO:0007264), regulation of actin cytoskeleton organization (GO:0032956), collateral sprouting (GO:0048668), positive regulation of collateral sprouting (GO:0048672)
GO Molecular Function (5): GTPase activity (GO:0003924), GTP binding (GO:0005525), protein kinase binding (GO:0019901), nucleotide binding (GO:0000166), protein binding (GO:0005515)
GO Cellular Component (5): acrosomal membrane (GO:0002080), cytosol (GO:0005829), plasma membrane (GO:0005886), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
Reactome top-level categories
Rollup of top-4 pathways:
| Category | Pathways |
|---|---|
| RHO GTPase cycle | 1 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 1 |
| Signaling by Rho GTPases | 1 |
| Signal Transduction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| actin cytoskeleton organization | 2 |
| cytoplasm | 2 |
| cellular anatomical structure | 2 |
| supramolecular fiber organization | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| intracellular signaling cassette | 1 |
| regulation of actin filament-based process | 1 |
| regulation of cytoskeleton organization | 1 |
| axonogenesis | 1 |
| developmental cell growth | 1 |
| developmental growth involved in morphogenesis | 1 |
| positive regulation of cell growth | 1 |
| positive regulation of developmental growth | 1 |
| collateral sprouting | 1 |
| regulation of collateral sprouting | 1 |
| positive regulation of axonogenesis | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| kinase binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| binding | 1 |
| acrosomal vesicle | 1 |
| secretory granule membrane | 1 |
| membrane | 1 |
| cell periphery | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
2394 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RND2 | PLXNB1 | O43157 | 853 |
| RND2 | ARHGAP35 | Q9NRY4 | 810 |
| RND2 | NEUROG2 | Q9H2A3 | 795 |
| RND2 | TNFAIP1 | Q13829 | 752 |
| RND2 | KCTD13 | Q8WZ19 | 720 |
| RND2 | IFI35 | P80217 | 716 |
| RND2 | NBR1 | Q14596 | 695 |
| RND2 | PRAG1 | Q86YV5 | 636 |
| RND2 | PLXNB2 | O15031 | 620 |
| RND2 | ARF3 | P16587 | 594 |
| RND2 | ROCK1 | Q13464 | 590 |
| RND2 | RAP2B | P17964 | 587 |
| RND2 | NEUROG1 | Q92886 | 548 |
| RND2 | RRAS | P10301 | 526 |
| RND2 | RHOBTB3 | O94955 | 479 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RND2 | USP47 | psi-mi:“MI:0915”(physical association) | 0.590 |
| RND2 | PLXNB1 | psi-mi:“MI:0407”(direct interaction) | 0.560 |
| RND2 | PLXNB2 | psi-mi:“MI:0407”(direct interaction) | 0.560 |
| Fnbp1 | RND2 | psi-mi:“MI:0915”(physical association) | 0.520 |
| SLC25A25 | HAX1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (444): RND2 (Two-hybrid), USP47 (Affinity Capture-MS), RND2 (Two-hybrid), ARHGAP5 (Affinity Capture-Western), ARHGAP5 (Reconstituted Complex), RND2 (Reconstituted Complex), RND2 (Affinity Capture-Western), RND2 (Reconstituted Complex), UBXN11 (Two-hybrid), RND2 (Reconstituted Complex), USP47 (Affinity Capture-MS), ANKRD26 (Affinity Capture-MS), IGF2R (Affinity Capture-MS), CKAP4 (Affinity Capture-MS), DEPDC1B (Affinity Capture-MS)
ESM2 similar proteins: A2WSI7, A4D1S5, A8HN58, A8XAD0, O00194, O13876, P10949, P25378, P33519, P34443, P35294, P36019, P38543, P38545, P38546, P38547, P38548, P41914, P41916, P41917, P41918, P41919, P41925, P51152, P52198, P54765, P54766, P62823, P62824, P91580, Q18969, Q1HE58, Q23862, Q55CA9, Q55CB7, Q55CC0, Q5M7U5, Q5ZHV1, Q6DHC1, Q76NM7
Diamond homologs: A8HME3, O77683, P52198, P61587, P61588, Q381A3, Q4R4K5, Q567Y6, Q5E9J4, Q5FVJ7, Q5M8K8, Q5R9F4, Q6SA80, Q9DAI2, Q9H7X7, Q9QYM5, A0A286QZ36, C4YDI6, O00212, O42825, O76321, O88931, O96390, P01122, P06780, P08134, P0CY33, P15153, P17081, P19073, P22122, P24406, P34144, P34145, P34146, P34148, P34149, P34150, P40792, P40793
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
39 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 35 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
651 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:43025435:G:GT | donor_gain | 1.0000 |
| 17:43025447:GGG:G | donor_gain | 1.0000 |
| 17:43025448:GGG:G | donor_gain | 1.0000 |
| 17:43025958:A:AG | acceptor_gain | 1.0000 |
| 17:43025959:G:GG | acceptor_gain | 1.0000 |
| 17:43025959:GA:G | acceptor_gain | 1.0000 |
| 17:43025959:GAGTT:G | acceptor_gain | 1.0000 |
| 17:43027179:TCAGG:T | acceptor_loss | 1.0000 |
| 17:43027180:CAGGT:C | acceptor_loss | 1.0000 |
| 17:43027181:A:AC | acceptor_loss | 1.0000 |
| 17:43027276:A:T | donor_gain | 1.0000 |
| 17:43027289:GAAG:G | donor_gain | 1.0000 |
| 17:43027290:AAGGT:A | donor_loss | 1.0000 |
| 17:43027291:AGG:A | donor_loss | 1.0000 |
| 17:43027293:G:GA | donor_loss | 1.0000 |
| 17:43027294:T:G | donor_loss | 1.0000 |
| 17:43028057:ATAGT:A | acceptor_gain | 1.0000 |
| 17:43028058:T:G | acceptor_gain | 1.0000 |
| 17:43028059:A:AG | acceptor_gain | 1.0000 |
| 17:43028060:G:GG | acceptor_gain | 1.0000 |
| 17:43025448:GG:G | donor_gain | 0.9900 |
| 17:43025449:GG:G | donor_gain | 0.9900 |
| 17:43025450:G:GA | donor_loss | 0.9900 |
| 17:43025450:G:GG | donor_gain | 0.9900 |
| 17:43025451:T:A | donor_loss | 0.9900 |
| 17:43025455:GGACC:G | donor_gain | 0.9900 |
| 17:43025955:TGCA:T | acceptor_loss | 0.9900 |
| 17:43025957:CAG:C | acceptor_gain | 0.9900 |
| 17:43025957:CAGA:C | acceptor_loss | 0.9900 |
| 17:43025958:A:AC | acceptor_loss | 0.9900 |
AlphaMissense
1464 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:43025387:G:A | G14R | 1.000 |
| 17:43025387:G:C | G14R | 1.000 |
| 17:43025388:G:A | G14E | 1.000 |
| 17:43025978:T:C | F41L | 1.000 |
| 17:43025980:T:A | F41L | 1.000 |
| 17:43025980:T:G | F41L | 1.000 |
| 17:43026035:T:A | W60R | 1.000 |
| 17:43026035:T:C | W60R | 1.000 |
| 17:43026038:G:C | D61H | 1.000 |
| 17:43026039:A:C | D61A | 1.000 |
| 17:43026039:A:G | D61G | 1.000 |
| 17:43026039:A:T | D61V | 1.000 |
| 17:43027246:G:A | C85Y | 1.000 |
| 17:43027247:C:G | C85W | 1.000 |
| 17:43028061:T:A | W101R | 1.000 |
| 17:43028061:T:C | W101R | 1.000 |
| 17:43028063:G:C | W101C | 1.000 |
| 17:43028063:G:T | W101C | 1.000 |
| 17:43028119:A:T | K120I | 1.000 |
| 17:43025388:G:T | G14V | 0.999 |
| 17:43025402:G:C | G19R | 0.999 |
| 17:43025403:G:A | G19D | 0.999 |
| 17:43025403:G:T | G19V | 0.999 |
| 17:43025405:A:C | K20Q | 0.999 |
| 17:43025406:A:T | K20M | 0.999 |
| 17:43025407:G:C | K20N | 0.999 |
| 17:43025407:G:T | K20N | 0.999 |
| 17:43025415:T:C | L23P | 0.999 |
| 17:43025418:T:C | L24P | 0.999 |
| 17:43025979:T:G | F41C | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000135325 (17:43031175 A>T), RS1000165862 (17:43027009 C>T), RS1000213974 (17:43032371 G>T), RS1000709241 (17:43026576 G>A), RS1001004139 (17:43025189 C>G,T), RS1001163066 (17:43031469 T>C), RS1001477657 (17:43029824 A>G), RS1002175148 (17:43029756 G>A), RS1002640160 (17:43031898 G>A), RS1003007133 (17:43026387 C>G,T), RS1003062623 (17:43024731 CG>C), RS1003294085 (17:43023740 T>C), RS1003324077 (17:43031757 T>A), RS1003755960 (17:43023946 T>C), RS1003993934 (17:43030738 G>A)
Disease associations
OMIM: gene MIM:601555 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005194_158 | Coronary artery disease | 6.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases expression | 5 |
| trichostatin A | affects cotreatment, decreases expression | 3 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Decitabine | affects expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Aspirin | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Carbamazepine | affects expression | 1 |
| Cisplatin | affects expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Fluorouracil | increases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Lipopolysaccharides | affects cotreatment, increases expression | 1 |
| Mercury | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tamoxifen | decreases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.